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Background: Infectious spleen and kidney necrosis virus (ISKNV) belongs to the genus Megalocytivirus from the
family Iridoviridae. Megalocytivirus causes severe economic losses to tropical freshwater and marine culture industry
in Asian countries and is devastating to the mandarin fish farm industry in China particularly.
Methods: We investigated the involvement of microfilaments in the early and late stages of ISKNV infection in
MFF-1 cells by selectively perturbing their architecture using well-characterized inhibitors of actin dynamics. The
effect of disruption of actin cytoskeleton on ISKNV infection was evaluated by indirect immunofluorescence analysis
or real-time quantitative PCR.
Results: The depolymerization of the actin filaments with cytochalasin D, cytochalasin B, or latrunculin A reduced
ISKNV infection. Furthermore, depolymerization of filamentous actin by inhibitors did not inhibit binding of the
virus but affected virus internalization in the early stages of infection. In addition, the depolymerization of actin
filaments reduced total ISKNV production in the late stages of ISKNV.
Conclusions: This study demonstrated that ISKNV required an intact actin network during infection. The findings
will help us to better understand how iridoviruses exploit the cytoskeleton to facilitate their infection and
subsequent disease.
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Intracellular pathogens are well known to use and ma-
nipulate cellular machinery to accomplish their life cycle.
The infection cycle of animal viruses can be divided into
three essential steps: entry into a host cell, replication,
and egression to ultimately infect another cell. The
restrictions of free diffusion in the cytoplasm and the
limited coding capacity of viruses force them to manipu-
late cellular metabolic pathways to achieve each of these
steps [1]. Most viruses utilize the cytoskeleton, including
actin microfilaments (F-actin) and microtubules, for
various stages of their life cycle. The shape of cells, as* Correspondence: gchangj@mail.sysu.edu.cn
1MOE Key Laboratory of Aquatic Product Safety/State Key Laboratory for
Biocontrol, School of Marine Sciences, Sun Yat-sen University, 135 Xingang
Road West, Guangzhou 510275, PR China
Full list of author information is available at the end of the article
© 2013 Jia et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the orwell as phagocytosis, intercellular communication and
the distribution of organelles, depend on actin microfila-
ments [2]. Microfilaments are the polymers of the pro-
tein actin, which exists in monomeric form as globular
actin and in filamentous form as filamentous actin [3].
The actin microfilaments often have interesting and sur-
prising roles that are not always well understood. The
actin cytoskeleton of the host cell is often co-opted by a
virus at different stages of its life cycle to facilitate the
infection process [4]. The actin and microtubule cyto-
skeletons are responsible for the trafficking of numerous
endogenous cargos, as well as intracellular microorgan-
isms, such as viruses, throughout the cell [3,5-7]. As
obligate intracellular parasites, viruses use the host actin
and microtubule transport systems and their motors at
every step during their infection cycle, such as attach-
ment, internalization, endocytosis, nuclear targeting,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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particles, assembly, exocytosis, and cell-to-cell spread
[1,3,4,8,9]. Numerous viral proteins have been reported
to interact with actin-binding proteins or directly with
actin, such as the baculovirus VP80 protein [10], the NS3
and NS5A proteins (where NS indicates non-structural) of
hepatitis C virus [11], the NS1 protein of influenza A [12],
and Gag of equine infectious anemia virus [13].
Iridoviruses are large icosahedral cytoplasmic DNA
viruses that contain circularly permutated, terminally
redundant, double-stranded DNA genomes [14]. The
current members of the family Iridoviridae are divided
into five genera: Iridovirus, Chloriridovirus, Ranavirus,
Lymphocystivirus, and Megalocytivirus [15]. Megalocytiviruses
have been implicated in more than 50 fish species infec-
tions and currently threaten the aquaculture industry, caus-
ing great economic losses in China, Japan, and Southeast
Asia [16,17]. Infectious spleen and kidney necrosis virus
(ISKNV) is the type species of the genus Megalocytivirus,
causing severe damage in mandarin fish (Siniperca chuatsi)
cultures in China [18]. We have previously demonstrated
that ISKNV enters mandarin fish fry 1 (MFF-1) cells
through a caveola-mediated internalization mechanism,
and the microtubules of MFF-1 cells may play a role in the
entry of ISKNV [19]. However, involvement of actin fila-
ments in ISKNV infection has not been looked at so far. In
the present study, we investigated the involvement of mi-
crofilaments in the early and late stages of ISKNV infection
in MFF-1 cells by selectively perturbing their architecture
using well-characterized pharmacological agents. Our re-
sults suggested that the microfilaments played an important
role in ISKNV infection.Results
Depolymerization of microfilaments
We first determined the concentrations of drugs, at
which actin microfilaments are disassembled. Cyto D,
cyto B and lat A are actin-binding drugs with different
modes of action. Lat A binds to monomeric (G)-actin in
a 1:1 complex and disrupts polymerization [20]; Cyto D
and cyto B bind to F-actin at the barbed ends and
disrupts polymerization [21]. When MFF-1 cells were
treated with cyto D (5 μM) or cyto B (0.5 μg/ml), the
microfilaments in the cytoplasmic region were signifi-
cantly reduced (Figure 1B and C). Addition of lat A
(5 μM) caused the collapse of the cytoplasm and an al-
most total disappearance of the microfilaments under
the membrane (Figure 1D). In contrast, in untreated
cells, intact bundles of actin stress fibers spanned the en-
tire cytosol (Figure 1A). These data clearly demonstrate
the rapid and specific effects of drugs on microfilament
disruption under experimental conditions. The results of
cell viability and toxicological tests showed that cellviability was not compromised despite treatment of cells
with drugs for as long as 72 h (Figure 1E).
Effect of disruption of actin cytoskeleton on ISKNV
infection
In order to determine if the actin cytoskeleton is re-
quired for ISKNV infection, we treated MFF-1 cells with
a panel of chemical inhibitors at a concentration deter-
mined by the above experiments. Cells were fixed and
examined for the expression of ISKNV ORF101L pro-
tein, a viral structural protein, by immunofluorescence
48 h post-infection (hpi) (Figure 2, panels 1, 4, and 7).
As shown in Figure 2A, the infection rates of ISKNV
were 50.8% and 23.5% in the presence of 0.2 and 0.5 μg/
ml of cyto B, respectively, which were significantly
smaller than the infection rates of the positive control
(99.1%). A similar situation was detected in cells treated
with cyto D or lat A. The infection rates of ISKNV were
34.6% and 17.1% in the presence of 2 μM and 5 μM of
cyto D, respectively, which were significantly smaller
than the infection rates of the positive control (98.2%)
(Figure 2B). The infection rates of ISKNV were 45% and
22.4% in the presence of 2 μM and 5 μM of lat A, re-
spectively, which were smaller than the infection rates of
the positive control (98.8%) (Figure 2C). Untreated and
uninfected cells served as negative control (Figure 2D).
Effects of actin filaments on early stages of ISKNV
infection
Because the preceding experiments in this work showed
that depolymerization of actin microfilaments caused a
significant decrease in the expression of ISKNV ORF101L,
we performed a number of experiments to investigate the
role of microfilaments in early ISKNV infection. Results
showed that ISKNV DNA levels were similar in control,
cyto B, cyto D and lat A treated cells (Figure 3A),
suggesting that depolymerization of actin microfilaments
did not affected binding of ISKNV to MFF-1 cells.
Internalization of virus was measured in the presence
of cyto B, cyto D or lat A just as described in the mate-
rials and methods. The relative amount of viral DNA in
each treatment indicated the number of virus particles
that had entered the cells. Data analysis showed that
ISKNV DNA levels were reduced in cyto B (74.8%), cyto
D (76%) and lat A (84.1%) treated cells compared with
control cells (Figure 3).
Effects of actin filament depolymerization on late stages
of ISKNV infection
To evaluate further the involvement of the actin
microfilaments in the viral life cycle steps after entry,
ISKNV-infected MFF-1 cells were incubated with differ-
ent concentrations of inhibitors. To differentiate be-
tween effects on distinct viral processes, we performed
Figure 1 Effects of drugs on actin microfilaments of MFF-1 cells. MFF-1 cells were treated for 2 h with 5 μM cyto D (B), 0.5 μg/ml cyto B (C),
or 5 μM lat A (D), Mock- treated MFF-1 cells were used as control (A). (E) Cell viability was measured using the Cell Counting Kit 8 (CCK-8). The
scale bar represents 10.0 μm.
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methods. Results showed that ISKNV production was
decreased for cyto B and cyto D treated cells compared
to control (Figure 4). Virus collected from the superna-
tants was reduced by cyto B incubation in a dose-
dependent manner with a 42.9% reduction at 0.5 μg/ml
of cyto B compared with that in untreated cells (Figure 4A).
To determine whether the reduced viral budding induced
by cyto B treatment was a common effect of actin filament-
disrupting drugs, we also tested cyto D, another reagent
that specifically depolymerizes actin filaments. Similarly, a
20.8% decrease in virion production was detected in the su-
pernatants of cells treated with this compound (5 μM)
(Figure 4C).
We also examined the amount of virus present in the
cell-associated fraction from these samples. The results
showed that the inhibitors caused a great reduction in
viral growth in the cell-associated fraction. Treatment
with the inhibitors resulted in inhibition of viral DNA by
approximately 58.6% and 64.6% for cyto B and cyto D,
respectively, compared with the control (Figure 4B andD). To determine the effect of the total mount of virus,
we summed the intracellular and extracellular viruses in
each mock or drug treated samples. In drug treated cells
virus levels remained significantly (p<0.05) lower,
suggesting that there was less virus overall (data not
shown).
Discussion
Many viruses have been reported to exploit the host
cellular machinery throughout their life cycle due to
their parasitic nature and simplicity [22]. Several reports
showed that the cytoskeleton plays an important role in
the intracellular traffic of some viruses [9,23-26]. Frog
virus 3 (FV3) was found to interact with the cytoskel-
eton and disrupt the actin cytoskeleton at the initial
stages of infection [27]. Treatment of infected cells with
cytochalasin has been demonstrated to affect the release
of FV3 at the plasma membrane level. Tiger frog virus
(TFV) was reported to cause the reorganization of
microtubules in infected zebrafish embryo fibroblast 4
(ZF4) cells [28].
Figure 2 Effects of disruption of microfilaments on ISKNV infection. (A) MFF-1 cells were treated with 0.2 μg/ml (2) or 0.5 μg/ml cyto B (3),
Mock- treated MFF-1 cells were used as control (1). (B) MFF-1 cells were treated with 2 μM (5) or 5 μM cyto D (6), Mock- treated MFF-1 cells were
used as control (4). (C) MFF-1 cells were treated with 2 μM (8) or 5 μM lat A (9), Mock- treated MFF-1 cells were used as control (7) (D) Mock-
treated and uninfected MFF-1 cells were used as negative control. Numbers at the bottom right of each panel refer to the percentages of
infected cells per field and represent the mean of at least four fields of cells from each of three independent experiments. The ISKNV ORF101L
expression of infected cells was detected by indirect immunofluorescence (green).
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of the actin filaments with cyto D, cyto B, or lat A
reduced ISKNV infection, the virus blockage at the entry
step of its life cycle potentially caused the reduced
ISKNV infection. In addition, the depolymerization of
actin filaments reduced both the total amount of virus
produced in the cell and the amount of virus that was
allowed to egress from cells in the late stages of ISKNV
infection. These data demonstrate that ISKNV relies on
an intact actin network during infection.
Increasing evidence has showed that the actin cyto-
skeleton is involved in many endocytic pathways,
although to varying degrees [29]. Entry by endocytosis
may require remodeling of the actin cytoskeleton, while
fusion at the cell surface might not rely as heavily on the
actin cytoskeleton [28]. Our results showed that
microfilament depolymerization did not change virus
binding to the cell, but it efficiently inhibited virusinternalization. Many previous reports have demon-
strated that microfilaments are dispensable for viral
binding to the host cell [30-32]. The role of microfila-
ments in viral internalization may be useful to better
understand the precise entry mechanism of ISKNV.
Actin filaments have been shown to be essential for
infection by several other viruses [23,33,34]. Using
inhibitor depolymerizing actin filaments, we evaluated
the effect of disrupting actin systems on the infectivity
of ISKNV. Our results indicated that disruption of
microfilaments with cyto D, cyto B, or lat A inhibited
the infection of MFF-1 cells by ISKNV. Furthermore,
using qPCR, we found that disrupting microfilaments
inhibited early steps of virus entry. However, the disrup-
tion of microfilaments could not inhibit the virus entry
completely, which could be attributed to a caveola-
mediated internalization mechanism through which
ISKNV enters MFF-1 cells. Similar to other viruses,
Figure 4 Effects of actin depolymerization on late stages of ISKNV inf
concentrations of cyto B (A, B) or cyto D (C, D) for 72 h at 27°C. Each expe
represent the mean value with the standard deviation of the reduplicates.
statistically significant (P<0.05) compared to the untreated control (Mock).
Figure 3 Intact actin filaments are required for virus
internalization. (A) Effects of disruption of microfilaments on ISKNV
binding; (B) Effects of disruption of microfilaments on ISKNV
internalization. All samples were subjected to qPCR analysis and the
levels of MCP DNA relative to those of actin were determined and
are represented as fold DNA change relative to control (Mock). The
asterisks indicate that the difference between the mean value is
statistically significant (P<0.05) compared to the untreated control.
Jia et al. Virology Journal 2013, 10:77 Page 5 of 9
http://www.virologyj.com/content/10/1/77ISKNV might use more than one route to enter cells. In
this case, inhibition of one pathway might not affect viral
entry via another pathway, resulting in a reduced number
of viral particles entering the cells [35]. In fact, cells have
been demonstrated to upregulate alternate endocytic routes
if an endocytic pathway is blocked [36]. Moreover, caveolae
and caveolin-associated signaling proteins and receptors
have been reported to be linked to a dynamic filamentous
actin network via structural proteins [37]. The disruption of
actin may destroy the caveola-mediated internalization
mechanism through which ISKNV enters MFF-1 cells and
then impede ISKNV infection. Further studies are needed
to clarify the role of actin in caveola-mediated endocytosis
during ISKNV entry and trafficking in MFF-1 cells.
We also sought to determine the effect of inhibitors
on later stages of viral replication. In the present study,
we evaluated the replication ability of ISKNV in pres-
ence of actin inhibitors and found a significant reduction
in virus replication. These results indicate that the mi-
crofilaments are possibly involved in an interaction with
the viral replication machinery. Several reports have
shown that actin microfilaments participate in late stages
of viral replication, such as assembly and release [38].
Treatment with the cyto D, the Autographa californica
nucleopolyhedrovirus budding from host cells was
drastically inhibited [39]. Cyto D caused numerous
microvillus-like projections containing virions and actin
microfilaments to accumulate on the infected cell sur-
face in the late stage of frog virus 3 infections [27]. The
utilization of a cellular cytoarchitecture for viral replica-
tion has also been reported in several viruses, such as
human parainfluenza virus type 3 [40], mouse mammaryection. Infected MFF-1 cells were incubated with increasing
riment was repeated independently at least three times. The data
The asterisks indicate that the difference between the mean value is
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known about the accurate kinetics of ISKNV replication
cycle. Our results showed that treatment with cyto D
and cyto B reduced total ISKNV production (Figure 4),
but which late step(s) of the viral life was affected by mi-
crofilaments should be further studies. All these results
suggested that actin filaments played an important role in
viral replication cycle in vitro using the MFF-1 cell line.
In addition, many viruses may employ the actin and
microtubule network to transport their nucleocapsids
protein [43]. Nucleocapsids of the murine mammary
tumor virus have been found to interact with actin with
this interaction reported to be necessary for extruding
virus particles from infected cells [44]. Xiong et al.
(2011) suggested that the ISKNV major capsid protein
(MCP) gene interacts with the β-actin of zebrafish. In our
study, we also find that the actin of MFF-1 cells interacts
with the MCP of ISKNV by co-immunoprecipitation (data
not shown). All the results provide strong evidence that the
actin network potentially participates in ISKNV intracellu-
lar traffic and the release of virus from cells.Conclusions
In summary, we have studied the roles of actin filaments
in ISKNV infection, and found that they played an
important role in the entry into MFF-1 cells and later
stages of ISKNV replication cycle.Materials and methods
Cells and virus
MFF-1 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco, USA) supplemented
with 10% (v/v) fetal bovine serum (Gibco, USA) and
passaged every 3–4 days by trypsinization, in a mono-
layer at 27°C, in a humidified atmosphere with 5% CO2.
The ISKNV (ISKNV strain NH060831) used in this
study was originally isolated from diseased mandarin fish
and maintained by our laboratory.Antibodies and reagents
The rabbit polyclonal anti-ORF101L antisera used in this
study was generated previously by our laboratory [45].
Alexa FluorW488-labeled goat anti-mouse IgG, Alexa
FluorW488-labeled anti-rabbit secondary antibody and
Hoechst 33342 were purchased from Invitrogen (Eugene,
OR, USA). Cytochalasin D, cytochalasin B and latrunculin
A were obtained from Sigma-Aldrich (St. Louis, MO,
USA). Cytochalasin D was reconstituted in DMSO to a
concentration of 100 μM and stored at -20°C. Cytochalasin
B was reconstituted in DMSO to a concentration of 10 μg/
ml and stored at -20°C. Latrunculin A was reconstituted in
DMSO to a concentration of 100 μM and stored at -20°C.Cell viability assay
Cell viability and toxicological tests with inhibitors were
performed as previously described, using Cell Counting
Kit 8 (CCK-8) [19].
Depolymerization of microfilaments
MFF-1 cells were grown to 70% confluence on cover
slips. Collapse of the actin filaments was achieved by
treating MFF-1 cells with 5 μM lat A, 5 μM cyto D,
0.5 μg/ml of cyto B or solvent only for 2 h at 27°C.
Following either mock treatment or a given cytoskeleton
treatment, the cells were fixed and stained to evaluate
the action of the corresponding drug.
Treated MFF-1 cells were washed three times in
phosphate-buffered saline (PBS) and fixed in 4% parafor-
maldehyde for 10 min to visualize the actin filaments.
Ten minutes of permeabilization in 1% Triton X-100
was followed by a 30 min blocking step in 5% goat
serum to reduce non-specific binding. The cells were
then incubated with 1:100 dilution of mouse anti-actin
antibody (Abcam, USA) for 1 h at 37°C. After three
washes in PBS, the primary antibody was recognized by
a secondary goat anti-mouse Alexa FluorW488-labeled
antibody used at 1:300 dilution for 1 h at 37°C. The cells
were washed and mounted on glass slides with Hoechst
33342. Samples were viewed and evaluated under a
confocal microscope (Zeiss LSM510) equipped with
555/488 nm argon/krypton and 543 nm helium/neon
lasers.
Indirect immunofluorescence analysis of ISKNV infection
ISKNV-infected MFF-1 cells were fixed in 4% parafor-
maldehyde after 48 hpi to detect the expression of
ISKNV ORF101L. Cells were washed three times with
PBS and permeabilized with 1% Triton X-100 in PBS for
10 min. Cells were rinsed three times with PBS, and
non-specific binding was reduced by blocking with 5%
goat serum for 30 min at RT. Cells were incubated with
anti-ORF101L antibody and in PBST (PBS plus 0.05%
Tween-20) containing 5% goat serum for 60 min at RT.
Cells were rinsed three times for 10 min with PBST and
incubated with Alexa FluorW488-labeled anti-rabbit
secondary antibody at a dilution of 1:1000 for 1 h. The
cover slips were then washed several times with PBST
and mounted with Hoechst 33342. Samples were viewed
and evaluated under a confocal microscope (Zeiss
LSM510) equipped with 555/488 nm argon/krypton and
543 nm helium/neon lasers.
Measurement of virus binding and internalization
For virus binding assays, MFF-1 cells were grown on 6-
well plates overnight to achieve 70–80% confluency and
then pretreated with cyto B, cyto D or lat A for 2 h at
27°C. The cells were then inoculated with ISKNV at a
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the inhibitors at 4°C for 1 h. After washed three times
with PBS, DNA was isolated using E.Z.N.A.WTissue
DNA Kit (Omega, USA) and the number of virus copies
bound cell was determined by qPCR. To assess internal-
ization, cells were pretreated similar to the binding assay
above, and then ISKNV internalization was allowed to
proceed for 2 h at 27°C in the presence of the inhibitors.
At the end of the incubation period, cells were treated
with 1 mg/ml of proteinase K (Roche) in PBS with
10 mM EDTA for 10 min to remove virus remaining at
the cell surface. Total DNA of cell pellets was isolated
for qPCR.
Effect of disruption of actin cytoskeleton on ISKNV
infection
MFF-1 cells grown on 24-well plates at 80% to 90% con-
fluence were preincubated with lat A, cyto D, or cyto B
at different concentrations for 2 h at 27°C before infec-
tion. Their appropriate concentrations were determined
by titration (data not shown). Pretreated and untreated
MFF-1 cells were challenged with the virus at an MOI of
10 in the continued presence or absence of these drugs
for 4 h at 27°C, after which the virus inoculum was re-
moved. After cells were washed once with PBS, treated
cells were incubated with medium containing inhibitors
and untreated cells were incubated with normal medium
for 48 h at 27°C. Cells were fixed 48 hpi and stained for
ISKNV ORF101L expression as described above.
Production of budded virus in the presence of actin
filament inhibitors
In an assay to evaluate the production of budded virus
in the presence of actin filament inhibitors, MFF-1 cells
were grown on 24-well plates at 80% to 90% confluence
and incubated with the ISKNV at an MOI of 10 for 4 h
at 27°C. The virus inoculum was then removed, and the
cells were washed gently twice with fresh medium. Each
well were incubated with 500 μl of fresh medium with
or without different concentrations of cyto B or cyto D
at 27°C. This medium was sampled 72 hpi. All samples
were frozen at −80°C immediately after they were
taken. Virion production was measured by absolute
real-time qPCR. Each experiment was performed
twice independently.
Real-time qPCR
ISKNV-infected cells were incubated with different con-
centrations of the inhibitors for 72 h at 27°C, and the su-
pernatants and cell fractions were collected. Viral DNA
of the supernatants was extracted to analyze the inhib-
ition of release of virus by the compounds using
Purelink Viral RNA/DNA Mini Kit (Invitrogen) as
recommended by the manufacturer. The level of ISKNVGEs was determined by absolute real-time qPCR using
LightCycler 480 (Roche, Germany). Briefly, reactions
were performed in a 10 ml volume containing 2 ml
of total DNA, 5 ml of 2 × SYBRW Premix Ex TaqTM
(TaKaRa, China), 0.2 μl of ISKNV MCP-specific forward
primer (50-CAATGTAGCACCCGCACTGACC-03), and
0.2 μl of reverse primer (50-ACCTCACGCTCCTCGCT
TGTC- 03). A pCMV-myc-MCP vector containing one
copy of the ISKNV MCP gene was serially diluted 10-
fold (1011 to 104 copies) and used in parallel as a stand-
ard. The cycling parameters were as follows: one cycle of
95°C for 30 s and 40 cycles of 95°C for 5 s, 60°C for 20 s,
and 70°C for 20 s, followed by one cycle of 95°C at 5°C/s
calefactive velocity to generate the melting curve. Fluo-
rescence measurements were taken at 70°C for 0.1 s du-
ring each cycle. A standard curve of the Ct, based on
known amounts of plasmid DNA containing the MCP
gene, was determined by linear regression analysis. The
number of viral DNA molecules was then calculated by
using the equation of the straight line. p<0.05 was con-
sidered statistically significant, and the data were
expressed as mean ± standard deviation.
Total DNA of cell fractions was extracted for qPCR
analysis to analyze the inhibition of viral replication by
the compounds using E.Z.N.A.WTissue DNA Kit (Omega,
USA) according to the manufacturer’s instructions. Samples
were analyzed by qPCR using the following oligonucleo-
tides as described above: MCP-specific forward primer,
50-CAATGTAGCACCCGCACTGACC-30; MCP-specific
reverse primer, 5‘-ACCTCACGCTCCTCGCTTGTC-3’;
Actin-F, 5‘-CCCTCTGAACCCCAAAGCCA-3’; and Actin-
R, 5‘-CAGCCTGGATGGCAACGTACA-3’.
Inhibitor-treated MFF-1 cells were infected with
ISKNV at an MOI of 10 to analyze the inhibition of
virus entry by the compounds. At 4 hpi, total DNA was
extracted for qPCR analysis using E.Z.N.A.WTissue DNA
Kit according to the manufacturer’s instructions. Sam-
ples were analyzed by qPCR as described above. The CT
values for the cellular control gene actin were subtracted
from the DNA CT values, and the result was designated
as ΔCT. The average ΔCT value was determined for trip-
licate samples, and the numbers for each inhibitor were
compared with the ΔCT values for solvent alone. The
difference in changes between virus DNA levels with
the inhibitors and those without was calculated by
subtracting the ΔCT of the sample treated with solvent
alone from the ΔCT value in the presence of each of the
inhibitors, which yielded a ΔΔCT value. For ease of
interpretation, these values were converted into fold
differences using the equation of 2−ΔΔCT.
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